Randomized phase IIb study of nivolumab (anti-PD-1; BMS-936558, ONO-4538) alone or in combination with ipilimumab versus bevacizumab in patients (pts) with recurrent glioblastoma (GBM).


Conference Paper

Full Text

Duke Authors

Cited Authors

  • Sampson, JH; Vlahovic, G; Desjardins, A; Friedman, HS; Baehring, JM; Hafler, D; Rollin, L; Coric, V; Perez, SN; Reardon, DA

Published Date

  • May 20, 2014

Published In

Volume / Issue

  • 32 / 15_suppl

Start / End Page

  • TPS2101 - TPS2101

Published By

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X

Digital Object Identifier (DOI)

  • 10.1200/jco.2014.32.15_suppl.tps2101